Acinar cell carcinoma of the pancreas: Clinical and cytomorphologic characteristics

Korean Journal of Pathology

Volumn 47, Issue 2, 2013, Pages 93-99

  Toll, Adam D ^a   Hruban, Ralph H ^a   Ali, Syed Z ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Acinar cell; Carcinoma; Pancreas

Indexed keywords

EID: 84879213571     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.2.93     Document Type: Review

References (41)

1. Klimstra DS. Nonductal neoplasms of the pancreas. Mod Pathol 2007; 20 Suppl 1: S94-112.
2. Klimstra DS. Cell lineage in pancreatic neoplasm. In: Sarkar FH, Dugan MC, eds. Pancreatic cancer: advances in molecular pathology, diagnosis and clinical management. Natick: Biotechniques Books, 1998; 21-47.
3. Ohike N, Morohoshi T. Exocrine pancreatic neoplasms of nonductal origin: acinar cell carcinoma, pancreatoblastoma, and solid-pseudopapillary neoplasm. Surg Pathol Clin 2011; 4: 579-88.
4. Albores-Saavedra J. Acinar cystadenoma of the pancreas: a previously undescribed tumor. Ann Diagn Pathol 2002; 6: 113-5.
5. Zamboni G, Terris B, Scarpa A, et al. Acinar cell cystadenoma of the pancreas: a new entity?. Am J Surg Pathol 2002; 26: 698-704.
6. Chatelain D, Paye F, Mourra N, et al. Unilocular acinar cell cystadenoma of the pancreas an unusual acinar cell tumor. Am J Clin Pathol 2002; 118: 211-4.
7. Hruban RH, Pitman MB, Klimstra DS. AFIP atlas of tumor pathology series 4 fascicle 6: tumors of the pancreas. Washington, DC: American Registry of Pathology, 2007.
8. Wisnoski NC, Townsend CM Jr, Nealon WH, Freeman JL, Riall TS. 672 patients with acinar cell carcinoma of the pancreas: a populationbased comparison to pancreatic adenocarcinoma. Surgery 2008; 144: 141-8.
9. Schmidt CM, Matos JM, Bentrem DJ, Talamonti MS, Lillemoe KD, Bilimoria KY. Acinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinoma. J Gastrointest Surg 2008; 12: 2078-86.
10. Holen KD, Klimstra DS, Hummer A, et al. Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol 2002; 20: 4673-8.
11. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma: an analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993; 143: 685-98.
12. Ambrosini-Spaltro A, Potí O, De Palma M, Filotico M. Pancreatictype acinar cell carcinoma of the stomach beneath a focus of pancreatic metaplasia of the gastric mucosa. Hum Pathol 2009; 40: 746-9.
13. Terris B, Genevay M, Rouquette A, et al. Acinar cell carcinoma: a possible diagnosis in patients without intrapancreatic tumour. Dig Liver Dis 2011; 43: 971-4.
14. Coyne JD. Pure pancreatic-type acinar cell carcinoma of the stomach: a case report. Int J Surg Pathol 2012; 20: 71-3.
15. Agaimy A, Kaiser A, Becker K, et al. Pancreatic-type acinar cell carcinoma of the liver: a clinicopathologic study of four patients. Mod Pathol 2011; 24: 1620-6.
16. Burns WA, Matthews MJ, Hamosh M, Weide GV, Blum R, Johnson FB. Lipase-secreting acinar cell carcinoma of the pancreas with polyarthropathy: a light and electron microscopic, histochemical, and biochemical study. Cancer 1974; 33: 1902-9.
17. Takanami K, Abe K, Mitamura A, et al. Two cases of 18 F-FDG PET/ CT findings in acinar cell carcinoma of the pancreas. Clin Nucl Med 2009; 34: 209-12.
18. Tapia B, Ahrens W, Kenney B, Touloukian R, Reyes-Múgica M. Acinar cell carcinoma versus solid pseudopapillary tumor of the pancreas in children: a comparison of two rare and overlapping entities with review of the literature. Pediatr Dev Pathol 2008; 11: 384-90.
19. Mergo PJ, Helmberger TK, Buetow PC, Helmberger RC, Ros PR. Pancreatic neoplasms: MR imaging and pathologic correlation. Radiographics 1997; 17: 281-301.
20. Matos JM, Schmidt CM, Turrini O, et al. Pancreatic acinar cell carcinoma: a multi-institutional study. J Gastrointest Surg 2009; 13: 1495- 502.
21. Shah S, Mortele KJ. Uncommon solid pancreatic neoplasms: ultrasound, computed tomography, and magnetic resonance imaging features. Semin Ultrasound CT MR 2007; 28: 357-70.
22. García-Romero D, Vanaclocha F. Pancreatic panniculitis. Dermatol Clin 2008; 26: 465-70.
23. Kolb-van Harten P, Rosien U, Klöppel G, Layer P. Pancreatic acinar cell carcinoma with excessive alpha-fetoprotein expression. Pancreatology 2007; 7: 370-2.
24. Hiraoka A, Nakahara H, Kawasaki H, et al. Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFPL3). Intern Med 2012; 51: 1341-9.
25. Kitagami H, Kondo S, Hirano S, Kawakami H, Egawa S, Tanaka M. Acinar cell carcinoma of the pancreas: clinical analysis of 115 patients from Pancreatic Cancer Registry of Japan Pancreas Society. Pancreas 2007; 35: 42-6.
26. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas: a clinicopathologic study of 28 cases. Am J Surg Pathol 1992; 16: 815-37.
27. Seth AK, Argani P, Campbell KA, et al. Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature. J Gastrointest Surg 2008; 12: 1961-7.
28. Hartwig W, Denneberg M, Bergmann F, et al. Acinar cell carcinoma of the pancreas: is resection justified even in limited metastatic disease?. Am J Surg 2011; 202: 23-7.
29. de Wilde RF, Ottenhof NA, Jansen M, et al. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma. Mod Pathol 2011; 24: 1229-36.
30. Lowery MA, Klimstra DS, Shia J, et al. Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. Oncologist 2011; 16: 1714-20.
31. Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002; 160: 953-62.
32. Falcone A, Ricci S, Brunetti I, et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 2007; 25: 1670-6.
33. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-25.
34. Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24: 4677-84.
35. Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, Brinster RL. Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci U S A 1991; 88: 93-7.
36. Ohike N, Morohoshi T. Pathological assessment of pancreatic endocrine tumors for metastatic potential and clinical prognosis. Endocr Pathol 2005; 16: 33-40.
37. Ohike N, Kosmahl M, Klöppel G. Mixed acinar-endocrine carcinoma of the pancreas: a clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 2004; 445: 231-5.
38. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. Lyon: IARC Press, 2019; 314-30.
39. Stelow EB, Shaco-Levy R, Bao F, Garcia J, Klimstra DS. Pancreatic acinar cell carcinomas with prominent ductal differentiation: mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma. Am J Surg Pathol 2019; 34: 519-8.
40. Shimoike T, Goto M, Nakano I, et al. Acinar-islet cell carcinoma presenting as insulinoma. J Gastroenterol 1997; 32: 830-5.
41. Seki Y, Okusaka T, Ikeda M, Morizane C, Ueno H. Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent. Jpn J Clin Oncol 2009; 39: 751-5.